Progestin-only pills may be a better first-line treatment for endometriosis than combined estrogen-progestin contraceptive pills
review
OA: closed
CC0
⤵ 137 in-corpus citations
Limited metadata. Only one source feed has indexed
this record so far — no abstract, full text, or open-access copy is
available through Endo Lab. The
publisher's page (linked below)
is the canonical location for the actual content. If you have institutional
access, use "Find at my library".
AI-generated summary
This study found that progestin-only pills may be a more effective first-line treatment option for endometriosis compared to combined estrogen-progestin contraceptive pills.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
My notes (saved in your browser only)
Condition tags
MeSH descriptors
Citation neighborhood
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.
References (45)
- 17β-Hydroxysteroid Dehydrogenase-2 Deficiency and Progesterone Resistance in Endometriosis via openalex
- Combined blockade of angiotensin II type 1 receptor and activation of peroxisome proliferator-activated receptor- by telmisartan effectively inhibits vascularization and growth of murine endometriosis-like lesions via openalex
- Dienogest, a synthetic steroid, suppresses both embryonic and tumor-cell-induced angiogenesis via openalex
- Dienogest in the treatment of endometriosis-associated pelvic pain: a 12-week, randomized, double-blind, placebo-controlled study via openalex
- Dienogest is as effective as triptorelin in the treatment of endometriosis after laparoscopic surgery: results of a prospective, multicenter, randomized study via openalex
- Does Response to Hormonal Therapy Predict Presence or Absence of Endometriosis? via openalex
- Effect of dienogest administration on angiogenesis and hemodynamics in a rat endometrial autograft model via openalex
- Effect of norethindrone acetate in the treatment of symptomatic endometriosis. via openalex
- Effects of dienogest, a synthetic steroid, on experimental endometriosis in rats via openalex
- Endometriosis: Diagnosis and Management via openalex
- Endometriosis: Role of Ovarian Steroids in Initiation, Maintenance, and Suppression via openalex
- Estrogen-progestins and progestins for the management of endometriosis via openalex
- Estrogen Receptor-β, Estrogen Receptor-α, and Progesterone Resistance in Endometriosis via openalex
- Expression of oestrogen receptor-alpha and -beta in ovarian endometriomata via openalex
- Female Perspectives on Endometriosis: Findings from the Uterine Bleeding and Pain Women'S Research Study via openalex
- Low-dose oral contraceptive pill for dysmenorrhea associated with endometriosis: a placebo-controlled, double-blind, randomized trial via openalex
- MANAGEMENT OF ENDOMETRIOSIS WITH ORAL MEDROXYPROGESTERONE ACETATE via openalex
- Norethindrone acetate or dienogest for the treatment of symptomatic endometriosis: a before and after study via openalex
- Oral contraceptives and endometriosis: the past use of oral contraceptives for treating severe primary dysmenorrhea is associated with endometriosis, especially deep infiltrating endometriosis via openalex
- Oral contraceptives and risk of endometriosis: a systematic review and meta-analysis via openalex
- Placebo-controlled comparison of danazol and high-dose medroxyprogesterone acetate in the treatment of endometriosis via openalex
- Practice Bulletin No. 114: Management of Endometriosis via openalex
- Progestagens and anti-progestagens for pain associated with endometriosis via openalex
- Progesterone Receptor Isoform A But Not B Is Expressed in Endometriosis via openalex
- Progestins inhibit expression of MMPs and of angiogenic factors in human ectopic endometrial lesions in a mouse model via openalex
- Treatment of pelvic pain associated with endometriosis: a committee opinion via openalex
- W2101417341 via openalex
- W2152628855 via openalex
- W2154377312 via openalex
- W2163315477 via openalex
- W2170973793 via openalex
- W2070651949 via openalex
- W2228635764 via openalex
- W2051636067 via openalex
- W2272521481 via openalex
- W2021687464 via openalex
- W2009670845 via openalex
- W2000899261 via openalex
- W1968456293 via openalex
- W6607311167 via openalex
- W6638359506 via openalex
- W6658221620 via openalex
- W2134481084 via openalex
- W6669579114 via openalex
- W2145176599 via openalex
Cited by (50)
- Pharmacotherapy of Endometriosis: Balancing of Safety, Efficacy, and Adherence to Treatment 2026
- Short-term Use of GnRH Antagonist for Severe Pain in Endometriosis 2026
- Dienogest-associated capillaroscopic abnormalities: a case report and narrative review of progestin microvascular effects 2026
- Endometriosis-Associated Infertility: A Review of Pathophysiological Mechanisms and Current Treatment Strategies 2026
- Lignes directrices de pratique clinique n° 468 : Prise en charge clinique de l'endométriose 2026
- Algorithmen für die medikamentöse Therapie der Endometriose – Leitlinien im Vergleich 2025
- Hormonal Treatment of Endometriosis: A Narrative Review 2025
- Pharmacologic Interventions for Endometriosis-Related Pain 2025
- Endométriose : un nouveau paradigme pour le diagnostic et le traitement 2025
- Management of women with endometriosis in the 21st century 2025
- Breast cancer is a threatening scenario resulting from the development of endometriosis and benign breast disease overlap syndrome: literature review 2025
- Dienogest vs. combined oral contraceptive: A systematic review and meta‐analysis of efficacy and side effects to inform evidence‐based guidelines 2025
- Therapeutic effects and mechanisms of alcohol extracts from Polygala fallax Hemsl on endometriosis in rats 2025
- Endometriosis as a Risk Factor for Ischemic and Hemorrhagic Stroke: A Population-Based Cohort Study 2025
- Advances in the diagnosis and management of endometriosis: A comprehensive review 2025
- The development of a preclinical swine model for endometriosis 2025
- A multicentre phase III study comparing efficacy & safety of novel extended-release vs. conventional formulation of Dydrogesterone in Indian patients with endometriosis 2024
- Horizons in Endometriosis: Proceedings of the Montreux Reproductive Summit, 14-15 July 2023 2024
- Investigating migraine phenotype and dynamics in women with endometriosis: an observational pilot study 2024
- A multicentre phase III study comparing efficacy and safety of novel extended-release versus conventional formulation of dydrogesterone in Indian patients with endometriosis 2024
- Comparison of dienogest or combinations with ethinylestradiol/estradiol valerate on the pain score of women with endometriosis: A prospective cohort study 2024
- Endometriosis, pregnancy and delivery complications: Evidence from the US nationwide inpatient sample 2005-2018 2024
- Efficacy and Safety of Sanjie Analgesic Capsule in Patients with Endometriosis-Associated Pain: A Multicenter, 3:1 Randomized, Double-Blind, Placebo-Controlled Trial 2024
- Medical management of endometriosis 2024
- Efficacy and Safety of Oral Gonadotropin-Releasing Hormone Antagonist, Relugolix, in Endometriosis: A Meta-Analysis of Randomized Clinical Trials 2024
- Dienogest in conjunction with GnRH-a for postoperative management of endometriosis 2024
- Levonorgestrel intrauterine system versus dienogest effect on quality of life of women with deep endometriosis: a randomized open-label clinical trial 2024
- Comparative study on the effects of combined oral contraceptives and dienogest in women with endometriosis‑associated chronic pelvic pain 2024
- Nutrition in the Prevention and Treatment of Endometriosis 2024
- Advances in the Diagnosis and Management of Endometriosis: A Comprehensive Review 2024
- Linzagolix therapy versus a placebo in patients with endometriosis-associated pain: a prospective, randomized, double-blind, Phase 3 study (EDELWEISS 3) 2024
- Safety and efficacy of pharmacotherapies for pelvic inflammatory disease and endometriosis 2024
- Tanshinone ⅡA participates in the treatment of endometriosis by regulating adhesion, invasion, angiogenesis and inhibition of PI3K/Akt/mTOR signaling pathway 2023
- New approaches to the correction of immune disorders in adenomyosis 2023
- Aktuelle Aspekte der endokrinen Therapie der Endometriose und der Adenomyose 2023
- A review of phase II and III drugs for the treatment and management of endometriosis 2023
- Endometriosis: It’s time to change the pattern of pain, stigma and barriers to diagnosis and treatment 2023
- Medikamentöse Therapie der Endometriose – ein Update 2023
- El tratamiento hormonal es imperativo para todas las pacientes: lo antes posible y siempre 2023
- Tolerability of endometriosis medical treatment: a comparison between combined hormonal contraceptives and progestins 2023
- Exploring Patient Adherence to Post-Surgical Follow-Up in Pelvic Endometriosis 2023
- In the thicket of fears, doubts, and murky facts: some reflections on treatment modalities for endometriosis-associated pain 2023
- Tolerability of endometriosis medical treatment: a comparison between combined hormonal contraceptives and progestins 2023
- A Lifelong Impact on Endometriosis: Pathophysiology and Pharmacological Treatment 2023
- Efficacy of Dienogest on Pelvic Pain and Dyspareunia: Comprehensive Meta-Analysis and Systematic Review 2023
- Disease Burden of Dysmenorrhea: Impact on Life Course Potential 2023
- Epigenetic Dysregulation in Endometriosis: Implications for Pathophysiology and Therapeutics 2023
- Proposal for targeted, neo-evolutionary-oriented secondary prevention of early-onset endometriosis and adenomyosis. Part II: medical interventions 2023
- Spontaneous recurrent menstrual pneumothorax: a case report 2023
- Efficacy of Low-Dose Estrogen–Progestins and Progestins in Japanese Women with Dysmenorrhea: A Systematic Review and Network Meta-analysis 2022
Source provenance
- europepmc
- last seen: 2026-06-11T06:19:48.454388+00:00
- openalex
- last seen: 2026-06-10T17:14:06.276822+00:00
- pubmed
- last seen: 2026-05-13T22:20:37.704673+00:00
- unpaywall
- last seen: 2026-06-02T02:00:03.124865+00:00
License: CC0
· commercial use OK